Privia Health Group (NASDAQ:PRVA) Earns “Market Outperform” Rating from JMP Securities

Privia Health Group (NASDAQ:PRVA)‘s stock had its “market outperform” rating reiterated by research analysts at JMP Securities in a research note issued to investors on Friday,Benzinga reports. They currently have a $26.00 price objective on the stock. JMP Securities’ target price would suggest a potential upside of 3.48% from the company’s current price.

A number of other analysts have also recently commented on PRVA. Needham & Company LLC initiated coverage on Privia Health Group in a research report on Friday, January 10th. They issued a “buy” rating and a $25.00 price objective for the company. Truist Financial upped their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Stephens reiterated an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Barclays upped their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective on the stock. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $24.94.

Privia Health Group Stock Up 1.0 %

Shares of PRVA stock traded up $0.26 during mid-day trading on Friday, hitting $25.13. 375,878 shares of the stock were exchanged, compared to its average volume of 569,920. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $25.49. The firm has a fifty day moving average of $21.54 and a 200 day moving average of $20.20. The company has a market cap of $3.02 billion, a PE ratio of 251.23, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87.

Institutional Trading of Privia Health Group

Several institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC increased its stake in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares during the period. First Horizon Advisors Inc. grew its stake in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after buying an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. acquired a new stake in shares of Privia Health Group during the 4th quarter worth about $51,000. Finally, Quarry LP boosted its holdings in shares of Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.